Dividend Distribution - The company plans to distribute a cash dividend of 1.50 RMB per 10 shares (including tax) based on the total share capital on the dividend announcement date[5]. - The company reported a cash dividend of 61,062,450 CNY for the year 2017, representing 45.77% of the net profit attributable to ordinary shareholders[85]. - The company intends to distribute a cash dividend of 1.50 CNY per 10 shares for the 2017 fiscal year, pending shareholder approval[86]. - The cash dividend policy requires a minimum of 40% of profit distribution to be in cash, reflecting the company's mature development stage[86]. - The company reported a total distributable profit of 152,156,285.87 CNY for the year 2017[86]. Financial Performance - The company's operating revenue for 2017 was ¥1,183,780,419.01, representing a year-over-year increase of 9.07% compared to ¥1,085,361,917.11 in 2016[19]. - The net profit attributable to shareholders for 2017 was ¥133,413,773.96, which is a 9.06% increase from ¥122,334,208.09 in 2016[19]. - The net profit after deducting non-recurring gains and losses decreased by 5.65% to ¥119,021,341.64 in 2017 from ¥126,151,193.06 in 2016[19]. - The net cash flow from operating activities fell by 35.76% to ¥120,550,300.20 in 2017, down from ¥187,658,077.95 in 2016[19]. - Total assets at the end of 2017 were ¥2,413,071,607.97, reflecting a 10.26% increase from ¥2,188,605,493.60 at the end of 2016[20]. - The net assets attributable to shareholders increased by 19.00% to ¥1,887,505,993.79 at the end of 2017, compared to ¥1,586,102,819.83 at the end of 2016[20]. - The company reported a basic earnings per share of ¥0.3574 for 2017, up 5.18% from ¥0.3398 in 2016[19]. Market Position and Products - The company reported a significant focus on the development of phosphate-related products, which are crucial for agricultural and industrial applications[10]. - The company emphasizes the importance of its phosphate products in various sectors, including agriculture and pharmaceuticals, highlighting its market relevance[10]. - The company maintains a leading market share in both domestic and export markets for its feed-grade phosphoric acid products[29]. - The company’s main product, feed-grade dicalcium phosphate, accounted for 67.67% of total revenue, with a revenue of CNY 801.12 million, up 5.04% year-on-year[42]. - The ammonium phosphate segment saw a significant increase in revenue by 25.84%, reaching CNY 281.69 million, which constituted 23.80% of total revenue[42]. - The company’s international sales contributed CNY 418.23 million, representing 35.33% of total revenue, with a slight increase of 0.93% year-on-year[42]. Research and Development - The total R&D expenditure was ¥35,057,203.72, which is 2.96% of the operating revenue, down from 3.32% in the previous year[54]. - The company completed the technical review of a new filling material project using semi-hydrated phosphogypsum, which is expected to significantly reduce mining costs and improve recovery rates[51]. - The company achieved a total of 4 patents in 2017, including 3 invention patents, bringing the cumulative total to 50 patents by the end of the year[52]. - The company has a total of 48 domestic authorized patents and 2 PCT patents, with over 30 additional patents under review[33]. Operational Efficiency - The company is enhancing its production capacity by upgrading its existing phosphoric acid production facilities, which will improve product quality and reduce costs[31]. - The company plans to utilize up to ¥200,000,000 of temporarily idle raised funds for cash management, primarily for purchasing safe and liquid investment products[31]. - The sales volume in the chemical industry was 427,261.91 tons, an increase of 11.32% year-on-year[46]. - The cost of phosphorite accounted for 25.13% of the total operating costs, with a total cost of ¥221,257,606.20, reflecting a 24.76% increase from the previous year[47]. Governance and Compliance - The company has engaged Xinyong Zhonghe Accounting Firm for auditing, ensuring the accuracy and reliability of its financial reports[18]. - The company has not undergone any changes in its controlling shareholders, maintaining consistent governance[17]. - The company has established a commitment to adhere to the rules regarding share transfers and reductions as stipulated by the China Securities Regulatory Commission[89]. - The company has not reported any non-standard audit reports for the reporting period[101]. - The company has established a robust governance structure with independent operation of its board, supervisory board, and management[183]. Strategic Initiatives - The company plans to focus on a circular economy and clean production, with high-performance feed phosphates and new fertilizers as the main products[75]. - The company aims for both organic growth and external expansion through capacity enhancement and strategic acquisitions[77]. - The company is committed to technological advancements, particularly in improving phosphorus absorption in animals and developing specialized fertilizers for saline-alkali land[76]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[90]. Environmental Responsibility - The company adheres to national environmental protection laws and regulations, focusing on technological innovation to minimize environmental impact[128]. - The company has implemented a 60Kt/a ammonium phosphate tail gas washing and dust removal project with a total investment of 7 million RMB, completed in January 2017[131]. - The company has constructed a 300m³/h wastewater treatment facility and a 6000m³ emergency water pool, completed in December 2017[131]. - The company is classified as a key pollutant discharge unit, with various pollutants exceeding the emission standards, including total phosphorus and SO2[130]. Employee Development - The company emphasizes employee training and development to enhance overall workforce quality and provide promotion opportunities[128]. - The company has established a training program that includes new employee orientation, skill enhancement training, and partnerships with universities for professional knowledge training[176]. - The company has a total of 451 million CNY in remuneration for directors and senior management during the reporting period[174]. - The company employs 540 production personnel, 36 sales personnel, and 126 technical personnel, indicating a strong focus on production and technical capabilities[174]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% driven by new product launches and market expansion strategies[90]. - Future guidance estimates a revenue growth of 12% for 2018, with a target of reaching 1.35 billion RMB[168]. - The company plans to expand its production capacity by 30% in the next fiscal year to meet rising market demand[168]. - Investment in new technology for production efficiency is projected to reduce costs by 5% over the next two years[168].

Financial Performance - Revenue for Q1 2018 was CNY 220,681,721.64, a decrease of 7.21% compared to CNY 237,831,469.75 in the same period last year [8]. - Net profit attributable to shareholders was CNY 4,016,244.10, down 87.27% from CNY 31,537,843.35 year-on-year [8]. - Net profit excluding non-recurring gains and losses was CNY 2,291,045.27, a decline of 90.99% compared to CNY 25,441,449.58 in the previous year [8]. - Basic earnings per share decreased by 88.58% to CNY 0.0100 from CNY 0.0876 year-on-year [8]. - Total profit decreased by 85.86% primarily due to a decline in gross margin and increased exchange losses [17]. - The net profit attributable to shareholders for the first half of 2018 is expected to range from 17.99 million to 44.99 million RMB, representing a decrease of 50% to 80% compared to the same period in 2017 [21]. - The decline in net profit is attributed to rising raw material prices, increased operating costs, and a decrease in gross margin year-on-year [21]. Cash Flow and Assets - Operating cash flow showed a net outflow of CNY 61,438,752.78, an increase of 275.63% from a net outflow of CNY 16,356,029.52 in the same period last year [8]. - Total assets at the end of the reporting period were CNY 2,447,686,067.82, an increase of 1.43% from CNY 2,413,071,607.97 at the end of the previous year [8]. - The weighted average return on equity was 0.21%, down from 1.97% in the previous year [8]. Financial Management - Other receivables increased by 142.08% primarily due to reclassification of accounts and an increase in petty cash [16]. - Financial expenses rose by 209.83% mainly due to increased exchange losses and decreased loan interest subsidies [16]. Corporate Governance - The company has completed the registration of the 2017 equity incentive plan during this period [19]. - The company has established a Sino-foreign joint venture as part of its external investment strategy [19]. - The company reported no overdue commitments from major shareholders or related parties during the reporting period [20]. - There were no violations regarding external guarantees during the reporting period [22]. - The company did not engage in any non-operating fund occupation by controlling shareholders or related parties during the reporting period [23]. - No research, communication, or interview activities were conducted during the reporting period [24].

Financial Performance - The total revenue for 2017 was not explicitly stated in the provided content, but the company emphasized the importance of accurate financial reporting[4]. - The company's operating revenue for 2017 was ¥1,183,780,419.01, representing a year-over-year increase of 9.07% compared to ¥1,085,361,917.11 in 2016[19]. - The net profit attributable to shareholders for 2017 was ¥133,413,773.96, up 9.06% from ¥122,334,208.09 in 2016[19]. - The net profit after deducting non-recurring gains and losses decreased by 5.65% to ¥119,021,341.64 in 2017 from ¥126,151,193.06 in 2016[19]. - The net cash flow from operating activities fell by 35.76% to ¥120,550,300.20 in 2017, down from ¥187,658,077.95 in 2016[19]. - Total assets at the end of 2017 reached ¥2,413,071,607.97, reflecting a 10.26% increase from ¥2,188,605,493.60 at the end of 2016[20]. - The net assets attributable to shareholders increased by 19.00% to ¥1,887,505,993.79 at the end of 2017, compared to ¥1,586,102,819.83 at the end of 2016[20]. - The basic earnings per share for 2017 was ¥0.3574, a 5.18% increase from ¥0.3398 in 2016[19]. - The company reported a total distributable profit of 152,156,285.87 CNY for the year 2017[86]. - The company reported a cash dividend of 61,062,450 CNY for the year 2017, representing 45.77% of the net profit attributable to shareholders[85]. Business Operations - The company has not changed its main business since its listing, indicating stability in operations[17]. - The company is headquartered in Guizhou Province, with its registered address in Fuquan City, Longchang Town[14]. - The company has appointed Xinyong Zhonghe Accounting Firm for auditing, ensuring compliance and accuracy in financial reporting[18]. - The company has a continuous supervision agreement with Guohai Securities, indicating ongoing oversight of its financial practices[18]. - The board of directors has confirmed the authenticity and completeness of the annual report, highlighting corporate governance[4]. - The company has outlined potential risks in its future development, which are detailed in the operational discussion section[5]. - The company has not reported any changes in its controlling shareholders, indicating stability in ownership[17]. - The company’s stock is listed on the Shenzhen Stock Exchange under the code 002895, reflecting its public trading status[14]. Market and Product Development - The company maintains a leading market share in both domestic and export markets for its feed-grade dicalcium phosphate and fire-fighting ammonium phosphate products[29]. - The company has established a strong brand presence with its "Chanphos" product, recognized as a leading brand in the Asia-Pacific region[33]. - The company has a total of 48 domestic patents and 2 PCT patents, with over 30 additional patents pending[33]. - The company has been actively expanding its international market presence, exporting to over 40 countries and regions[34]. - The company plans to upgrade its production facility to a 150,000 tons/year semi-dry method phosphoric acid production line, enhancing production efficiency and product quality[31]. - The company aims to optimize its production processes and improve product quality to meet customer needs, with a focus on maintaining its leading position in the segmented industry[75]. - The company plans to enhance its marketing service system by providing comprehensive phosphorus nutrition solutions for animals and plants, aiming to strengthen relationships with strategic customers[76]. Research and Development - Research and development expenses amounted to ¥35,057,203.72, which is 2.96% of total revenue, down from 3.32% in the previous year[54]. - The company completed the technical review of a new filling material project using semi-hydrated phosphogypsum, which is expected to significantly reduce mining costs[51]. - The company has implemented a training program focusing on new employee orientation, skill enhancement, and professional development[176]. - The company has allocated 50 million RMB for R&D in new technologies aimed at improving production efficiency by 20%[162]. Financial Management - The company has initiated cash management using temporarily idle raised funds, with a total of ¥40,000,000 invested in bank financial products, yielding an investment income of ¥562,419.23[31]. - The company reported a decrease in financial expenses by 22.08% to ¥5,659,186.48 due to changes in accounting standards[50]. - The net cash flow from investing activities increased by 425.93% year-on-year, mainly due to funds raised for purchasing financial products and recoveries[55]. - The net cash flow from financing activities decreased by 1,888.09% year-on-year, primarily due to the timing of fund receipts[55]. - The company raised approximately ¥239.99 million through its initial public offering, with all funds currently held in a dedicated account for cash management[66]. Compliance and Governance - The company emphasizes compliance with self-regulatory rules of the stock exchange to avoid penalties[89]. - The company has committed to maintaining transparency in information disclosure during any share reduction activities[89]. - The company has established a transparent information disclosure system, ensuring timely and accurate communication with shareholders[180]. - The company has no significant differences in governance compared to the regulatory standards set by the China Securities Regulatory Commission[181]. - The company has not reported any standard audit report issues for the reporting period[101]. - The audit opinion for the financial statements was a standard unqualified opinion, confirming fair representation of the company's financial position as of December 31, 2017[199]. Shareholder Relations - The company will not repurchase shares held by major shareholders during the lock-up period[88]. - The company will disclose the details of the buyback plan, including the number of shares, price range, and completion timeline[95]. - The company emphasizes the importance of transparency and compliance with legal regulations in all business operations and related party transactions[92]. - The company has established measures to stabilize its stock price if it falls below the audited net asset value per share for 20 consecutive trading days[93]. Environmental and Social Responsibility - The company adheres to national environmental protection laws and regulations, focusing on technological innovation to minimize environmental impact[128]. - The company has implemented a 60Kt/a ammonium phosphate tail gas treatment project with a total investment of 7 million RMB, completed in January 2017[131]. - The company has constructed a 300m³/h wastewater treatment facility, which was completed in December 2017 and passed environmental acceptance[131]. - The company emphasizes social responsibility, focusing on shareholder rights protection and maintaining stable relationships with suppliers and customers[127]. Employee Relations - The total number of employees in the company is 1,096, with 570 in the parent company and 526 in major subsidiaries[174]. - The company emphasizes employee training and development to enhance overall workforce quality and provide promotion opportunities[128]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounts to 451,000 yuan[174]. - The company has a diversified and differentiated compensation policy based on job value, employee capability, and performance[175].

Financial Performance - Operating income for the current period was CNY 310,383,470.65, a slight decrease of 0.03% year-on-year[8]. - Net profit attributable to shareholders decreased by 23.68% to CNY 38,320,768.13 compared to the same period last year[8]. - Basic earnings per share decreased by 24.66% to CNY 0.1051[8]. - The weighted average return on equity was 2.32%, down by 0.90% year-on-year[8]. - The company reported non-recurring gains and losses totaling CNY 13,390,628.44 for the year-to-date[9]. - The estimated net profit attributable to shareholders for 2017 is expected to range from 12,233 to 15,291 million yuan, representing a change of 0.00% to 25.00% compared to the previous year[18]. Asset and Shareholder Information - Total assets increased by 9.07% to CNY 2,387,013,584.77 compared to the end of the previous year[8]. - Net assets attributable to shareholders increased by 18.69% to CNY 1,882,578,730.51 compared to the end of the previous year[8]. - The total number of shareholders at the end of the reporting period was 27,795[12]. - The largest shareholder, Sichuan Chuanheng Holdings Co., Ltd., holds 77.74% of the shares, with 310,968,000 shares pledged[12]. Cash Flow and Receivables - Net cash flow from operating activities decreased significantly by 68.20% to CNY 22,692,071.41[8]. - Cash received from operating activities increased by 114.52% year-on-year, mainly due to an increase in government subsidies related to income[16]. - Cash and cash equivalents increased by 59.13% compared to the beginning of the period, mainly due to the arrival of funds raised from the public offering[16]. - Accounts receivable increased by 45.04% compared to the beginning of the period, primarily due to an increase in customer credit period debts[16]. - Other receivables increased by 422.02% compared to the beginning of the period, mainly due to the increase in unsettled raw material taxes[16]. Expenses and Liabilities - Cash paid for the purchase of fixed assets increased by 545.38% year-on-year, primarily due to increased engineering projects and equipment purchases[16]. - Tax expenses increased by 362.09% year-on-year, mainly due to changes in accounting regulations[16]. - Other payables increased by 69.12% compared to the beginning of the period, mainly due to increased guarantees and accrued expenses for suppliers[16]. Future Outlook - The company expects stable sales revenue and increased government subsidies, leading to a reduction in non-operating expenses[18]. - Investment income increased by 441.82% year-on-year, mainly due to profits from joint ventures[16].